Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients;Prévalence et valeur pronostique des anticorps sériques anti-p53 au cours du carcinome hépatocellulaire. Etude chez 159 malades

Gastroenterologie Clinique et Biologique

Volumn 24, Issue 12, 2000, Pages 1159-1163

  Sitruk, Véronique ^a   Vaysse, Jenny ^a   Chevret, Sylvie ^b   Ganne Carrie, Nathalie ^a   Christidis, Christos ^a   Trinchet, Jean Claude ^a   Beaugrand, Michel ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Anti p53 antibodies; Hepatocellular carcinoma; Prevalence; Prognosis; Survival

Indexed keywords

ALPHA FETOPROTEIN; CANCER ANTIBODY; PROTEIN P53; SERUM ALBUMIN;

AGED; ALCOHOL CONSUMPTION; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER SURVIVAL; CHRONIC LIVER DISEASE; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK FACTOR; VIRUS INFECTION;

AGED; ALPHA-FETOPROTEINS; ANALYSIS OF VARIANCE; ANTIBODIES, ANTINUCLEAR; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034524294     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. P53 mutation in human cancers
2. Prognostic signifiance of p53 mutation and 3p deletion in primary resected non-small cell lung cancer
3. Mutation of the p53 gene as a predictor of poor prognosis in patients with non-small cell lung cancer
4. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
5. Gastric cancer with p53 overexpression has high potential for metastasis to lymph nodes
6. Mutational hotspot in the p53 gene in human hepatocellular carcinoma
7. Selective G to T mutation of the p53 gene in hepatocellular carcinoma from Southern Africa
8. The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas
9. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan
10. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellularcarcinoma undergoing surgical tumor ablation
11. p53 mutations in British patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis
12. Expression of mutant p53 protein in HCC
13. p53 mutations in human HCCs from Germany
14. Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction
15. Immune response to p53 is dependant upon p53 HSP70 complexes in breast cancer
16. Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma
17. Detection of antibodies against the cellular protein 53 in sera from patients with breast cancer
18. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alfa-fetoprotein
19. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
20. p53 antibodies in patients with various types of cancer: Assay, identification, and characterization
21. Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma
22. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
23. Prevalence of serum antibodies against the p53 tumour suppressor gene protein in various cancers
24. Use of specific ELISA for the detection of antibodies against p53 protein in patients with hepatocellular carcinoma
25. Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer
26. Antibodies against p53 are associated with poor prognosis of colorectal cancer
27. Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma
28. Transection of the oesophagus for bleeding oesophagal varices
29. p53 gene abnormalities are closely related to hepatoviral infections and occur at late stage of hepatocarcinogenesis
30. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma